4 ms·
A critical opinion piece on Theranos from the journal Clinical Chemistry and Laboratory Medicine: http://www.degruyter.com/view/j/cclm.2015.53.issue-7/cclm-201
by dbcooper 11y ago
A critical opinion piece on Theranos from the journal Clinical Chemistry and Laboratory Medicine:
http://www.degruyter.com/view/j/cclm.2015.53.issue-7/cclm-2015-0356/cclm-2015-0356.xml http://www.degruyter.com/view/j/cclm.2015.53.issue-7/cclm-20...
- sremani 11y agoThanks for the article, this quote hit me >> Details of the Theranos technology have not been disclosed to scientific journals and for this reason it is not possible to comment. << So they have handful of tests that are FDA approved and then their protocols or technology never went through scientific scrutiny, but the whole company is valued $9billion? This is disconcerting.
- cowsandmilk 11y agoWhat I find disconcerting is the faith Walgreen's has put in them. To be honest, their revenue plus the partnership with Walgreen's likely justifies the valuation. It is just that Walgreen's shouldn't partner with organizations for testing that aren't on solid scientific footing.
- hockeybias 11y agoAgreed.
- Nicholas_C 11y agoI would hope Walgreens at least did some due diligence.